GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-06-05 2:14:18 PM | Chg. +0.182 | Volume | Bid2:42:02 PM | Ask2:42:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.554EUR | +1.94% | 720 Turnover: 6,851.880 |
9.498Bid Size: 526 | 9.522Ask Size: 526 | 7.89 bill.EUR | - | 106.11 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...